Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 65.4 USD -0.4%
Market Cap: 12.5B USD
Have any thoughts about
Biomarin Pharmaceutical Inc?
Write Note

Revenue Breakdown

Breakdown by Geography
Biomarin Pharmaceutical Inc

Not Available

Breakdown by Segments
Biomarin Pharmaceutical Inc

Total Revenue: 2.4B USD
100%
Net Product Revenues: 2.4B USD
98.1%
Products Excluding Aldurazyme: 2.2B USD
92.6%
Aldurazyme: 131.2m USD
5.4%
Royalty And Other Revenues: 46.7m USD
1.9%
Show More
Show Less

See Also

Discover More